NCT00462618已完成2 期
Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 32
- 试验地点
- 1
- 主要终点
- PTSQ
研究概览
简要总结
The purpose of this pilot study is to assess feasibility and patient accessibility in order to design an adequately powered study to compare group cognitive behavioral therapy for insomnia (CBT-I) to quetiapine in non-demented patients aged 60 years or older with controlled bipolar disorder (I or II) or major depressive disorder who suffer from residual insomnia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age greater or equal to 60 years.
- •Patients with history of major affective disorder, including Bipolar disorder type I or type II or major depressive disorder, as assessed by the Structured Clinical Interview for DSM-IV (SCID), currently in remission.
- •Difficulty starting or initiating sleep four or more times/week for at least 3 months by history.
- •Total Pittsburg Sleep Quality Index >5.
排除标准
- •Patient in an acute mood episode as assessed by SCID
- •Patients with sleep disruptive medical problems including: sleep apnea, restless leg syndrome, periodic limb movement, parasomnia, congestive heart failure, chronic pain and chronic obstructive pulmonary disease as assessed by medical history and medical record review.
- •Patients with schizophrenia, primary anxiety disorder and active substance abuse as determined by SCID.
- •Patients on or with history of failure or intolerance to respond to quetiapine.
- •Patient with positive Alcohol Use Disorders Identification Test (AUDIT) with a total score above
- •Patients with dementia brain degenerative diseases, cognitive disorders and Mini Mental Status Examination (MMSE) score of less or equal to
- •Patients who are in an acute depressive, manic, hypomanic or mixed state as reflected by SCID
- •Patients on concurrent sedating medications that would confound interpretation of the results. This is operationalized as follow: Sedating medications must be present and stable dosage for at least 14 days prior to enrollment in the study. If the medication is not prescribed as a primary sleep aid, it will be continued. Our rationale is that patients may need these medications and the initial sedating effect will have plateaued by 14 days. However, medications prescribed to assist insomnia will be discontinued as they are not effective for the subjects who otherwise meet inclusion ad exclusion criteria for the current study. Medications will be tapered as clinically indicated after the patients sing informed consent and prior to baseline assessment.
研究组 & 干预措施
CBT
Active Comparator
干预措施: Quetiapine (Drug)
CBT
Active Comparator
干预措施: Cogntive behavioral therapy (Behavioral)
结局指标
主要结局
PTSQ
时间窗: 12 weeks
次要结局
未报告次要终点
研究者
Rayan Al Jurdi, MD
PI
Michael E. DeBakey VA Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Pilot Study of Cognitive Behavioral Therapy - Insomnia (CBT-I) Among Professional FirefightersShift-Work Related Sleep DisturbanceInsomniaNCT05087121Pacific University23
撤回
不适用
Cognitive Behavioral Therapy (CBT) for Late Life AnxietyGeneralized Anxiety DisorderNCT05380115Wake Forest University Health Sciences
已完成
不适用
Cognitive Behavioral Therapy for ObesityObesityNCT00569517US Department of Veterans Affairs32
已完成
不适用
Rehabilitation for Functional Memory Symptoms After ConcussionMild Traumatic Brain InjuryFunctional Neurological DisorderNCT05581810University of British Columbia30
已完成
不适用
Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic DisorderBody Dysmorphic DisorderNCT01002326Massachusetts General Hospital13